Verona Pharma plc - SPONSORED ADS (VRNA)

Historical Portfolio Holders from Q2 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q3 2024
67.4M
Holdings value Q3 2024
$1.94B
Value change Q3 2024
+$161M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
147
Number of buys Q3 2024
83
Number of sells Q3 2024
-63
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 67.4M $1.94B +$161M $28.77 149
2024 Q2 65.8M $952M -$14.9M $14.46 125
2024 Q1 66.6M $1.08B -$21.6M $16.09 112
2023 Q4 67.1M $1.34B +$15.3M $19.88 114
2023 Q3 64.9M $1.07B +$34.8M $16.30 98
2023 Q2 62.6M $1.33B +$50.2M $21.14 102
2023 Q1 60.3M $1.21B +$167M $20.08 93
2022 Q4 50.1M $1.31B +$111M $26.13 88
2022 Q3 51.8M $529M +$183M $10.22 67
2022 Q2 34.8M $146M -$8.61M $4.19 36
2022 Q1 36.4M $182M -$2.54M $4.99 38
2021 Q4 36.9M $248M +$379K $6.72 41
2021 Q3 37M $203M +$753K $5.48 38
2021 Q2 36.7M $240M +$947K $6.54 35
2021 Q1 36.5M $305M +$6.93M $8.36 37
2020 Q4 35.7M $246M +$8.1M $7.00 35
2020 Q3 34.1M $213M +$168M $6.24 28
2020 Q2 7.17M $33.6M +$912K $4.68 18
2020 Q1 6.98M $28.8M +$4.64M $4.12 14
2019 Q4 5.85M $33.7M +$46.4K $5.75 13
2019 Q3 5.86M $26.8M -$7.63M $4.57 12
2019 Q2 7.37M $37.6M -$77.8K $5.10 16
2019 Q1 7.38M $47.5M -$1.63M $6.50 17
2018 Q4 8.41M $78.6M -$2.82M $9.05 17
2018 Q3 7.38M $92.3M +$11M $12.51 14
2018 Q2 6.49M $71.1M -$1.25M $13.66 13
2018 Q1 6.58M $132M -$1.92M $20.00 14
2017 Q4 6.68M $79.3M +$6.21M $11.87 10
2017 Q3 5.28M $81M +$20.7M $15.35 9
2017 Q2 3.95M $46.1M +$46.1M $11.66 9